Kcentra 500 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFCA4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,376
Award facts
- Contract value 100% obligated
- $13,376.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $13,376 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500 unit vials of Kcentra. The delivery order, issued on February 4, 2026, with an ultimate completion date of February 26, 2026, carries firm fixed-price terms and includes no set-aside designation. This award leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to consolidate pharmaceutical procurement and streamline medical supply chain operations for Department of Defense healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with demonstrated performance across numerous delivery orders spanning oncology treatments, biologics, vaccines, specialty pharmaceuticals, and medical consumables. The company's PPV-G GEN V prime vendor contract, awarded in November 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions it to serve as one of multiple regional contractors supporting DOD healthcare operations globally. This Kcentra delivery order exemplifies the company's ongoing role in fulfilling specialized pharmaceutical requirements essential to military medical system operations.
Quick answers
Who was awarded contract SPE2DR26FFCA4?
SPE2DR26FFCA4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FFCA4 worth?
The government has obligated $13,376 on SPE2DR26FFCA4.
Is contract SPE2DR26FFCA4 an order under another contract?
Yes. SPE2DR26FFCA4 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFCA4 competed?
The extent of competition for SPE2DR26FFCA4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award